Inhibition mechanism of S-adenosylmethionine-induced movement deficits by prenylcysteine analogs

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 3-4, 2003, Pages 433-442

  Lamango, Nazarius S ^a   Ayuk Takem, Lambert T ^a   Nesby, Robert ^a   Zhao, Wan Qian ^a,b   Charlton, Clivel G ^a,b  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Methylation; Parkinson's disease; Prenylation; Prenylcysteine; S adenosyl L methionine; Tremor

Indexed keywords

ACETIC ACID DERIVATIVE; AMPHETAMINE; CYSTEINE DERIVATIVE; DOPAMINE; FARNESYL 2 ETHANESULFONIC ACID; FARNESYLSUCCINIC ACID; FARNESYLTHIOACETIC ACID; FARNESYLTHIOLACTIC ACID; FARNESYLTHIOTRIAZOLE; LACTIC ACID DERIVATIVE; METHYLTRANSFERASE; N ACETYLFARNESYLCYSTEINE; N ACETYLGERANYLCYSTEINE; N ACETYLGERANYLGERANYLCYSTEINE; PRENYLCYSTEINE; S ADENOSYLMETHIONINE; SUCCINIC ACID DERIVATIVE; SULFONIC ACID DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME ACTIVITY; HYPERACTIVITY; INCUBATION TIME; INHIBITION KINETICS; MALE; METHYLATION; MOTOR DYSFUNCTION; MOVEMENT (PHYSIOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SYNAPSE;

EID: 0344413540     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.08.017     Document Type: Article

References (36)

1. Aharonson Z., Gana-Weisz M., Varsano T., Haklai R., Marciano D., Kloog Y. Stringent structural requirements for anti-Ras activity of S-prenyl analogues. Biochim. Biophys. Acta. 1406:1998;40-50.
2. Anderegg R.J., Betz R., Carr S.A., Crabb J.W., Duntze W. Structure of Saccharomyces cerevisiae mating hormone a-factor. J. Biol. Chem. 263:1988;18236-18240.
3. Capdevila A., Decha-Umphai W., Song K.-H., Borchardt R.T., Wagner C. Pancreatic exocrine secretion is blocked by inhibitors of methylation. Arch. Biochem. Biophys. 345:1997;47-55.
4. Charlton C.G. Depletion of nigrostriatal and forebrain tyrosine hydroxylase by S-adenosylmethionine: a model that may explain the occurrence of depression in Parkinson's disease. Life Sci. 61:1997;495-502.
5. Charlton C.G., Crowell B. Jr. Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa. Pharmacol. Biochem. Behav. 43:1992;423-431.
6. Charlton C.G., Crowell B. Jr. Striatal dopamine depletion, tremors and hypokinesia following the intracranial injection of S-adenosylmethionine, a possible role of hypermethylation in Parkinsonism. Mol. Chem. Neuropathol. 26:1995;269-283.
7. Crowell B.G. Jr., Benson R., Shockley D., Chralton C.G. S-Adenosyl-L-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms. Behav. Neural Biol. 59:1993;186-193.
8. De Waard M., Liu H., Walker D., Scott V.E.S., Gurnett C.A., Campbell K.P. Direct binding of G-protein βγ complex to voltage-dependent calcium channels. Nature. 385:1997;446-450.
9. Ding J., Lu D.J., Perez-Sala D., Ma Y.T., Maddox J.F., Gilbert B.A.et al. Farnesyl-L-cysteine analogs can inhibit or initiate superoxide release by human neutrophils. J. Biol. Chem. 269:1994;16837-16844.
10. Fukada Y., Matsuda T., Kokame K., Takao T., Shimonishi Y., Akino T.et al. Effects of carboxyl methylation of photoreceptor G protein γ-subunit in visual transduction. J. Biol. Chem. 269:1994;5163-5170.
11. Fukuda T., Kobayashi S., Yukimasa H., Terao S., Fujino M., Shiba T.et al. Muramyl dipeptide derivatives with multiprenylacetyl group. Synthesis and immunological activities. Bull. Chem. Soc. Jpn. 54:1981;3530-3535.
12. Gudermann T., Kalkbrenner F., Schultz G. Diversity and selectivity of receptor-G protein interaction. Annu. Rev. Pharmacol. Toxicol. 36:1996;429-459.
13. Hayes J.S., Lawler O.A., Walsh M.T., Kinsella B.T. The prostacyclin receptor is isoprenylated. Isoprenylation is required for efficient receptor-effector coupling. J. Biol. Chem. 274:1999;23707-23718.
14. Honykiewicz O. Dopamine (3-hydroxytyramine) and function. Pharmacol. Rev. 18:1966;925-964.
15. Huzoor-Akbar, Wang W., Kornhauser R., Volker C., Stock J.B. Protein prenylcysteine analog inhibits agonist-receptor-mediated signal transduction in human platelets. Proc. Natl Acad. Sci. U. S. A. 90:1993;868-872.
16. Iniguez-Lluhi J.A., Simon M.I., Robishaw J.D., Gilman A.F. G protein βγ subunits synthesized in SF9 cells: functional characterization and significance of prenylation of γ J. Biol. Chem. 267:1992;23409-23417.
17. Lai R.K., Perez-Sala D., Canada F.J., Rando R.R. The gamma subunit of transducin is farnesylated. Proc. Natl. Acad. Sci. U. S. A. 87:1990;7673-7677.
18. Lamango N.S., Charlton C.G. Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats. Pharmacol. Biochem. Behav. 66:2000;841-849.
19. Lamango N.S., Nesby R.A., Charlton C.G. Quantitative determination of S-adenosylmethionine-induced tremors: a possible tremor model for Parkinson's disease. Pharmacol. Biochem. Behav. 65:2000;523-529.
20. Ma Y.T., Shi Y.Q., Lim Y.H., McGrail S.H., Ware J.A., Rando R.R. Mechanistic studies on human platelet isoprenylated protein methyltransferase: farnesylcysteine analogs block platelet aggregation without inhibiting the methyltransferase. Biochemistry. 33:1994;5414-5420.
21. Ma Y.T., Gilbert B.A., Rando R.R. Farnesylcysteine analogs to probe role of prenylated protein methyltransferase. Methods Enzymol. 250:1995;226-234.
22. Marom M., Haklai R., Ben-Baruch G., Marciano D., Egozi Y., Kloog Y. Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid. J. Biol. Chem. 270:1995;22263-22270.
23. Marshal C.J. Protein prenylation: a mediator of protein-protein interactions. Science. 259:1993;1865-1866.
24. Metz S.A., Rabaglia M.E., Stock J.B., Kowluru A. Modulation of insulin secretion from normal rat islets by inhibitors of the post-translational modifications of GTP-binding proteins. Biochem. J. 295:1993;31-40.
25. Myung C.S., Yasuda H., Liu W.W., Harden T.K., Garrison J.C. Role of isoprenoid lipids on the heterotrimeric G protein gamma subunit in determining effector activation. J. Biol. Chem. 274:1999;16595-16603.
26. Parish C.A., Smrcka A.V., Rando R.R. Functional significance of βγ-subunit carboxymethylation for the activation of phospholipase C and phosphoinositide 3-kinase. Biochemistry. 34:1995;7722-7727.
27. Perez-Sala D., Gilbert B.A., Tan E.W., Rando R.R. Prenylated protein methyltransferases do not distinguish between farnesylated and geranylgeranylated substrates. Biochem. J. 284:1992;835-840.
28. Perez-Sala D., Gilbert B.A., Rando R.R., Canada F.J. Analogs of farnesylcysteine induce apoptosis in HL-60 cells. FEBS Lett. 426:1998;319-324.
29. Pumiglia K.M., Levine H., Haske T., Habib T., Jove R., Decker S.J. A direct interaction between G-protein βγ subunits and the Raf-1 protein kinase. J. Biol. Chem. 270:1995;14251-14254.
30. Scheer A., Gierschik P. S-prenylated cysteine analogues inhibit receptor-mediated G protein activation in native granulocyte and reconstituted bovine retinal rod outer segment membranes. Biochemistry. 34:1995;4952-4961.
31. Sinensky M., Lutz R.J. The prenylation of proteins. BioEssays. 14:1992;25-31.
32. Tan E.W., Perez-Sala D., Canada F.J., Rando R.R. Identifying the recognition unit for protein methylation. J. Biol. Chem. 266:1991;10719-10722.
33. Tisch D., Halpern M., Marciano D., Kloog Y., Aviram I. Activation of signaling pathways in HL60 cells and human neutrophils by farnesylthiosalicylate. Eur. J. Biochem. 242:1996;529-536.
34. Volker C., Lane P., Kwee C., Johnson M., Stock J. A single activity carboxyl methylates both farnesyl and geranylgeranyl cysteine residues. FEBS. 295:1991;189-194.
35. 2+ entry into calls by farnesylcysteine analogs. Mol. Pharmacol. 50:1996;1495-1501.
36. Yamane H.K., Farnsworth C.C., Xie H.Y., Evans T., Howald W.N., Gelb M.H.et al. Membrane-binding domain of the small G protein G25K contains an S-(all-trans-geranylgeranyl) cysteine methyl ester at its carboxyl terminal. Proc. Natl. Acad. Sci. U. S. A. 88:1991;286-290.